Second pilot rapid assessment on ‘Renal denervation systems for treatment-resistant hypertension’
The purpose of the assessment is to assess the effectiveness and safety of renal denervation systems for patients who suffer from treatment-resistant hypertension compared to standard of care (no treatment, additional pharmacological treatment, device-based hypertension therapy and sham treatment).
Final version of the assessment was published in December 2013
Below is the documentation provided by the Joint Assessment authoring team:
Summary document of comments and author’s replies to the review